HB 352: Georgia Gestational Diabetes Management Act; enact
Última acción: 14 de mayo de 2025 · Effective Date 2025-07-01
Georgia House Bill 352 expands Medicaid coverage for continuous glucose monitors to include pregnant Medicaid recipients diagnosed with gestational diabetes, not just those on daily insulin or with severe hypoglycemia.
Los resúmenes de abajo son traducciones de resúmenes en inglés escritos por un modelo de IA (claude-sonnet-5) a partir del texto del proyecto de ley; no forman parte de él. El proyecto de ley está en inglés. Cite el texto, no el resumen. El texto almacenado es la versión Enrolled, la más reciente que tiene LegiScan.
El resumen en español de este proyecto de ley se está preparando. Mientras tanto se muestra el resumen en inglés.
En lenguaje claro
Georgia's Medicaid program already covers continuous glucose monitors for some people with diabetes, but only if they meet certain criteria, such as taking daily insulin or having a history of dangerous low blood sugar episodes. This bill, known as the Georgia Gestational Diabetes Management Act, adds a new qualifying condition: having gestational diabetes, a form of diabetes that develops during pregnancy. The bill amends Georgia's Medicaid statute (O.C.G.A. § 49-4-159.4) so that a Medicaid recipient can qualify for a continuous glucose monitor simply by having gestational diabetes, alongside the existing options of daily insulin use or a documented history of problematic hypoglycemia. It also updates the coverage start date referenced in the law from July 1, 2023 to July 1, 2025. The recipient must still be diagnosed by a treating practitioner and show sufficient training in using the device.
Qué hace el proyecto de ley
- Adds gestational diabetes as a qualifying condition for Medicaid coverage of continuous glucose monitors, without requiring daily insulin use or a hypoglycemia history.
- Updates the effective date in the Medicaid coverage statute (O.C.G.A. § 49-4-159.4) from July 1, 2023 to July 1, 2025.
- Keeps existing requirements that a treating practitioner diagnose the recipient with diabetes and confirm adequate training in using the monitor.
- Preserves the existing coverage paths for recipients on daily insulin or with a documented history of severe low blood sugar events.
A quién afecta
Pregnant Georgians on Medicaid who are diagnosed with gestational diabetes, along with the treating practitioners who diagnose and prescribe for them, and the Georgia Department of Community Health, which administers Medicaid coverage rules for continuous glucose monitors.
Por qué importa
Pregnant Medicaid recipients with gestational diabetes who previously did not qualify for coverage of a continuous glucose monitor because they were not on daily insulin or did not have a history of severe hypoglycemia could now get the device covered, potentially helping them track blood sugar during pregnancy.
Disposiciones clave
- Section 1 names the bill the 'Georgia Gestational Diabetes Management Act.'
- Section 2 amends O.C.G.A. § 49-4-159.4(a) to change the coverage start reference from July 1, 2023 to July 1, 2025.
- Section 2 adds 'has gestational diabetes' as a new standalone qualifying criterion alongside daily insulin use and problematic hypoglycemia history.
- Section 2 retains the requirement that a treating practitioner diagnose diabetes mellitus and confirm training in using the monitor before coverage applies.
- Section 3 repeals any conflicting laws.
Del proyecto de ley
“the department shall include coverage for continuous glucose monitors as a benefit under Medicaid via the most cost-effective benefit delivery channel”
“Has gestational diabetes”
Cronología del estado
- Effective Date 2025-07-01
- Act 260
- House Date Signed by Governor (Cámara de Representantes)
- House Sent to Governor (Cámara de Representantes)
- House Agreed Senate Amend or Sub (Cámara de Representantes)
- Senate Passed/Adopted By Substitute (Senado)
- Senate Third Read (Senado)
- Senate Taken from Table (Senado)
Mostrar el historial completo (18 acciones)
- Senate Tabled (Senado)
- Senate Read Second Time (Senado)
- Senate Committee Favorably Reported By Substitute (Senado)
- Senate Read and Referred (Senado)
- House Passed/Adopted By Substitute (Cámara de Representantes)
- House Third Readers (Cámara de Representantes)
- House Committee Favorably Reported By Substitute (Cámara de Representantes)
- House Second Readers (Cámara de Representantes)
- House First Readers (Cámara de Representantes)
- House Hopper (Cámara de Representantes)
Patrocinadores
- Devan Seabaugh (R, HD-034)
- Sharon Cooper (R, HD-045)
- Danny Mathis (R, HD-133)
- Darlene Taylor (R, HD-173)
- Teddy Reese (D, HD-140)
- Carter Barrett (R, HD-024)
- Kay Kirkpatrick (R, SD-032)
Votaciones
- Votación: Cámara de Representantes24 de febrero de 2025
169 a favor, 2 en contra (2 sin votar, 7 ausentes)
- Votación: Cámara de Representantes4 de abril de 2025
163 a favor, 2 en contra (3 sin votar, 12 ausentes)
- Votación: Senado4 de abril de 2025
51 a favor, 1 en contra (1 sin votar, 3 ausentes)
Temas
- Medicaid coverage
- gestational diabetes
- diabetes management
- maternal health
- continuous glucose monitors